Date post: | 05-Jul-2015 |
Category: |
Health & Medicine |
Upload: | amira-badr |
View: | 71 times |
Download: | 0 times |
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Pharmacology of Drugs AffectingPharmacology of Drugs AffectingAutonomic Nervous SystemAutonomic Nervous System
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Basic Functions of the Basic Functions of the Nervous SystemNervous System
Recognizing changes inRecognizing changes in Internal environmentInternal environment External environmentExternal environment
Processing and integrating environmental Processing and integrating environmental changeschanges
Reacting to environmental changes by Reacting to environmental changes by producing an action or response producing an action or response
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Two Major Divisions of the Two Major Divisions of the Nervous SystemNervous System
Central Nervous System (CNS)Central Nervous System (CNS) Brain and spinal cordBrain and spinal cord
Peripheral Nervous SystemPeripheral Nervous System all nervous tissues outside the CNS, including all nervous tissues outside the CNS, including
sensory and motor neuronssensory and motor neurons
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Divisions of human nervous Divisions of human nervous systemsystem
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Brain &
Spinal Cord
Nerves enter or leave
CNS
Carry massage from CNS to
peripheral tissues
Carry massage from
peripheral tissues to CNS
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Divisions of the Peripheral Divisions of the Peripheral Nervous SystemNervous System
Somatic nervous systemSomatic nervous system Voluntary control over skeletal musclesVoluntary control over skeletal muscles
Autonomic nervous systemAutonomic nervous system Involuntary control over smooth and cardiac Involuntary control over smooth and cardiac
muscle and glandsmuscle and glands
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Basic anatomy of ANS
Sympathetic NS Parasympathetic NS Enteric NS
Two main differences- Origin
- Function
-Collection of nerve fibers that innervate GIT, pancrease & gall bladder-Called “brain of gut”-They control motility, exocrine & endocrine secretion, as well asmicrocirculation of gut -Modulated by sympathatic & Parasympathatic systems
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Autonomic PharmacologyAutonomic Pharmacology
Autonomic Nervous SystemAutonomic Nervous System This system is divided into two separate This system is divided into two separate
systems.systems. These systems are called the parasympathetic These systems are called the parasympathetic
nervous system and the sympathetic nervous nervous system and the sympathetic nervous system.system.
These systems often produce opposite effects, These systems often produce opposite effects, but bbut branches do not always produce opposite effects.ranches do not always produce opposite effects.
Homeostasis – proper balance of the two Homeostasis – proper balance of the two branches achieved by changing one or both branches achieved by changing one or both branchesbranches
2
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Autonomic Nervous System: Sympathetic and Autonomic Nervous System: Sympathetic and Parasympathetic DivisionsParasympathetic Divisions
Drugs in this group are designed to either enhance or Drugs in this group are designed to either enhance or mimic the autonomic nervous system or to block the mimic the autonomic nervous system or to block the effects of the neurotransmitters at their receptor sites.effects of the neurotransmitters at their receptor sites.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Steps of NeurotransmissionSteps of Neurotransmission
Propagation of the nerve impulse in Propagation of the nerve impulse in the preganglionic nerve fiberthe preganglionic nerve fiber
+ + + + + + + + + + +- - - - - - - - - - - - - - --- - - - - - - - - - - - - -+ + + + + + + + + +
PolarizedResting Membrane Potential
+ + + + - - - - + + + - - - - - + + + + - - - - - - - - - + + + + - - - -
+ + + - - - - + +
DepolarizedNerve Action Potential
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Synaptic Transmission Synaptic Transmission
Synapse – junction of neuronsSynapse – junction of neurons Connection of two neurons outside CNS – Connection of two neurons outside CNS –
ganglionic synapse.ganglionic synapse.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Efferent neuronsEfferent neurons
Preganglionic neurons: Preganglionic neurons:
Cell body within CNSCell body within CNS Ganglia: aggregation of nerve cell bodies Ganglia: aggregation of nerve cell bodies
located in the peripheral nervous system.located in the peripheral nervous system. Postganglionic neurons: cell body originate in Postganglionic neurons: cell body originate in
the ganglia, terminates on effector organ.the ganglia, terminates on effector organ. Divided into sympathatic and Divided into sympathatic and
parasympathaticparasympathatic
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Origin
Symp. NSThoracolumbar
outflow
Parasymp. NS
Function
Craniosacral outflow
Short pre-ganglionic nerveLong post-ganglionic nerve
Long pre-ganglionic nerveShort post-ganglionic nerve
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Figure 13.4 Figure 13.4 Receptors in the autonomic nervous system: (a) sympathetic division; (b) parasympathetic divisionReceptors in the autonomic nervous system: (a) sympathetic division; (b) parasympathetic division
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Role of CNS in autonomic control Role of CNS in autonomic control functionsfunctions
CNS centers in hypothalamus, CNS centers in hypothalamus, medulla oblongata & spinal medulla oblongata & spinal
cordcord Reflex arcReflex arc EmotionsEmotions
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Organs Supplied by ANSOrgans Supplied by ANS
HeartHeart Smooth MusclesSmooth Muscles
- Eye Eye -Bronchi-Bronchi- GIT GIT - Urinary Bladder- Urinary Bladder- Blood VesselsBlood Vessels
GlandsGlands- Exocrine Glands: Lacrymal, Salivary, SweatExocrine Glands: Lacrymal, Salivary, Sweat- Endocrine Glands: Adrenal MedullaEndocrine Glands: Adrenal Medulla
MetabolismMetabolism LiverLiver Adipose TissueAdipose Tissue KidneyKidney
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Sympathetic Nervous SystemSympathetic Nervous System
Sympathetic Nervous SystemSympathetic Nervous System This nervous system is designed to This nervous system is designed to
cope with emergency situations. cope with emergency situations. This is commonly known as the “fright or This is commonly known as the “fright or
flight” response.flight” response. Its neurotransmitters are epinephrine Its neurotransmitters are epinephrine
and norepinephrine.and norepinephrine. Its receptors are the Its receptors are the αα and and ββ receptors. receptors.
4
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Sympathetic nervous systemSympathetic nervous system
Fight or flight response results in:Fight or flight response results in:
1.1. Increased BPIncreased BP
2.2. Increased blood flow to brain, heart and Increased blood flow to brain, heart and skeletal musclesskeletal muscles
3.3. Increased muscle glycogen breakdown for Increased muscle glycogen breakdown for energyenergy
4.4. Increased rate of coagulationIncreased rate of coagulation
5.5. Pupil dilationPupil dilation
parasympathatic Nervous parasympathatic Nervous SystemSystem
Parasympathetic Nervous SystemParasympathetic Nervous System This system is concerned with the This system is concerned with the
conservation of the body processes.conservation of the body processes. Activated under non stressful conditionsActivated under non stressful conditions Rest-and-digest responseRest-and-digest response Digestive processes promoted, heart rate Digestive processes promoted, heart rate
and blood pressure declineand blood pressure decline Its main neurotransmitter is Its main neurotransmitter is
acetylcholine.acetylcholine. Its receptors are muscarinic, nicotinic.Its receptors are muscarinic, nicotinic.
3
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Figure 13.2 Effects of the sympathetic and parasympathetic nervous systems. Figure 13.2 Effects of the sympathetic and parasympathetic nervous systems. Source: Biology Guide to the Natural Source: Biology Guide to the Natural World, 2World, 2ndnd ed (p. 558) by David Krogh, 2002 Upper Saddle River, NJ, Prentice Hall. Reprinted by permission. ed (p. 558) by David Krogh, 2002 Upper Saddle River, NJ, Prentice Hall. Reprinted by permission.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Symp. NS
Parasymp. NS
SingleInnervations
Dilator pupilae muscleAdrenal Medulla
VentriclesBV
Sweat GlandKidney
Constrictor pupillae muscle
Figure 13.1 Functional divisions of the peripheral nervous system. Figure 13.1 Functional divisions of the peripheral nervous system.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Primary Neurotransmitters of Primary Neurotransmitters of Autonomic Nervous SystemAutonomic Nervous System
Norepinephrine (NE)…………..adrenergic Norepinephrine (NE)…………..adrenergic neurotransmission neurotransmission
Acetylcholine (Ach)…………….cholinergic Acetylcholine (Ach)…………….cholinergic neurotransmissionneurotransmission
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
AcetylcholineAcetylcholine
Released byReleased by
1.1. All preganglionic nerve fibersAll preganglionic nerve fibers
2.2. Preganglionic sympathatic nerves to adrenal Preganglionic sympathatic nerves to adrenal medullamedulla
3.3. All postganglionic parasympathatic nervesAll postganglionic parasympathatic nerves
4.4. Postganglionic sympathatic nerve to sweat Postganglionic sympathatic nerve to sweat glandsglands
5.5. All somatic nerves.All somatic nerves.
6.6. CNS CNS
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Cholinergic Transmission (Cont.)Cholinergic Transmission (Cont.)
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Rate l imit ing step
ATP & proteoglycan
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Cholinergic Receptors
Muscarinic Receptors(Peripheral Cholinergic )
Nicotinic Receptors(Central Cholinergic) R.)
Strong affinity to muscarineWeak affinity to nicotine
Weak affinity to muscarineStrong affinity to nicotine
-Parasympathetic supplying effector organs-Sweat gland- CNS
-Autonomic ganglia (Nn)- Adrenal Medulla (Nn)- Neuromuscular junction (Nm)-CNS (Nn)
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Nicotinic receptorsNicotinic receptors Composed of 5-subunits and functions as ligand-gated channelComposed of 5-subunits and functions as ligand-gated channel
Binding of two Ach molecules elicits a conformational change that Binding of two Ach molecules elicits a conformational change that allows the entry of sodium ions, resulting in depolarization of the allows the entry of sodium ions, resulting in depolarization of the
effector celleffector cell
Nm (blocked by tubocurarine) differs from Nn (blocked by Nm (blocked by tubocurarine) differs from Nn (blocked by hexomethonium)hexomethonium)
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Muscarinic Receptors
M1 (Neural) M2 (Cardiac) M3 (Glandular)
- CNS- Gastric parietal cells
-CNS Presynaptically- Atria and conducting tissue
-Exocrine glands-Smooth muscles-Vascular endothelium
↑ Phospholipase C
Atropine & Pirenzepine
↓ Adenylate cyclase
Atropine & Gallamine
↑ Phospholipase C
Atropine
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Sympathatic neurotransmissionSympathatic neurotransmission
Norepinephrine is released by most Norepinephrine is released by most postganglionic sympathatic nervespostganglionic sympathatic nerves
Dopamine is released by postganglionic Dopamine is released by postganglionic nerves stimulating the kidney.nerves stimulating the kidney.
ACH is released by Postganglionic ACH is released by Postganglionic sympathatic nerve to sweat glandssympathatic nerve to sweat glands
Adrenal medulla acts as ganglia releasing Adrenal medulla acts as ganglia releasing epinephrine and NE.epinephrine and NE.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic TransmissionAdrenergic Transmission
Neurotransmitter:Neurotransmitter: Two catecholamines NA Two catecholamines NA & Ad& Ad
Sites of Release:Sites of Release:- Post ganglionic sympathetic nerve ending (80% NA & Post ganglionic sympathetic nerve ending (80% NA &
20% Ad)20% Ad)- Adrenal Medulla (80% Ad & 20% NA)Adrenal Medulla (80% Ad & 20% NA)- CNSCNS
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic receptorsAdrenergic receptors
αα——αα1 and 1 and αα22 ββ——ββ1, 1, ββ2, 2, ββ33 Dopamine—subsets D1-5Dopamine—subsets D1-5
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic Receptors
α Subtype β Subtype
↑ Phospholipase C ↓ Adenylate cyclase
α1 α2 β1, β2 & β3
↑ Adenylate cyclase
smooth muscles- Presynaptic adrenergic
nerve terminal-CNS
-β cells of pancreas
β1 (heart)β2 (smooth muscles)β3 (lipocytes)
Adrenergic Receptors
β Subtype
Adrenergic Receptors
α Subtype
Adrenergic Receptors
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
αα1-adrenergic Receptors1-adrenergic Receptors
In all sympathetic target organs except heartIn all sympathetic target organs except heart ResponseResponse
Constriction of blood vesselsConstriction of blood vessels Dilation of pupilsDilation of pupils Constriction of sphinctersConstriction of sphincters
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
αα2-adrenergic Receptors2-adrenergic Receptors
At presynaptic adrenergic neuron terminalsAt presynaptic adrenergic neuron terminals Activation inhibits release of norepinephrineActivation inhibits release of norepinephrine Inhibits release of insulinInhibits release of insulin
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
ββ1-adrenergic Receptors1-adrenergic Receptors
In heart and kidneysIn heart and kidneys ResponseResponse
Activation increases heart rate and force of Activation increases heart rate and force of contraction of heart.contraction of heart.
Increases release of reninIncreases release of renin
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
ββ2-adrenergic Receptors2-adrenergic Receptors
In all sympathetic target organs except the In all sympathetic target organs except the heartheart
Inhibit smooth muscle (relaxes)Inhibit smooth muscle (relaxes) Stimulates glycogenolysis and Stimulates glycogenolysis and
gluconeogenesisgluconeogenesis
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Organ Sympathetic R Parasympathetic R
Heart Stimulant β1 Depressant of atria M2
Smooth Musclesa- BV Constriction
Dilation(BV Sk. M.)
Kidney Vasculature
αβ2
D
No innervation(dilation by EDRF)
M3
b- Bronchi No innervation β2 Constriction↑ Secretion
M3M3
c- GITSmooth muscleSphincterGlands
↓ motilityConstriction
-----
β2α1
↑ motilityDilation
↑ Secretion↑Gastric acid
Enteric system
M3M3M3M1M1
d- Urinary BladderSmooth muscleSphincter
RelaxationConstriction
β2α1
ContractionDilation
M3M3
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Organ Sympathetic R Parasympathetic R
e- Eye: * Iris-Radial muscle-Circular muscle *Ciliary Muscle
Contraction
Relaxation (slight)
α1
β2ConstrictionContraction
M3M3
Glands:Salivary GlandsLacrimal GlandsSweat Glands:ThermoregulatoryApocrine (stress)
↑ SecretionNo effect
↑ Secretion↑ Secretion
α1, β2--------
M3α1
↑ Secretion↑ Secretion
M3M3
Metabolic Functions:Liver
Adipose tissueKidney
GluconeogenesisGlycogenolysisLipolysisRenin release
β2β2β3β1
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Five Mechanisms by Which Five Mechanisms by Which Drugs Can Affect Synaptic Drugs Can Affect Synaptic
TransmissionTransmission
1.1. Affect the synthesis of the neurotransmitter Affect the synthesis of the neurotransmitter in the presynaptic nerve.in the presynaptic nerve.
2.2. Prevent storage of the neurotransmitter in Prevent storage of the neurotransmitter in vesicles within the presynaptic nerve.vesicles within the presynaptic nerve.
3.3. Influence release of the neurotransmitter Influence release of the neurotransmitter from the presynaptic nerve.from the presynaptic nerve.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Five Mechanisms by Which Drugs Can Five Mechanisms by Which Drugs Can Affect Synaptic Transmission (cont'd)Affect Synaptic Transmission (cont'd)
4.4. Prevent the normal destruction or reuptake Prevent the normal destruction or reuptake of the neurotransmitter.of the neurotransmitter.
5.5. Bind to the receptor site on the postsynaptic Bind to the receptor site on the postsynaptic target tissuetarget tissue
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Drugs Not Given to Correct Drugs Not Given to Correct Autonomic Nervous SystemAutonomic Nervous System
System is relatively free of diseaseSystem is relatively free of disease Drugs used to stimulate or inhibit target Drugs used to stimulate or inhibit target
organs of the autonomic nervous systemorgans of the autonomic nervous system
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Classification and Naming of Classification and Naming of Autonomic DrugsAutonomic Drugs
Based on four possible actions of Based on four possible actions of sympathetic and parasympathetic nervous sympathetic and parasympathetic nervous systemssystems
1.1. Stimulate sympathetic nervous systemStimulate sympathetic nervous system Adrenergic agents or sympathomimeticsAdrenergic agents or sympathomimetics
1.1. Inhibit sympathetic nervous systemInhibit sympathetic nervous system Adrenergic-blocking agents, adrenergic Adrenergic-blocking agents, adrenergic
antagonists, or sympatholyticsantagonists, or sympatholytics
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Classification and Naming of Classification and Naming of Autonomic Drugs (cont'd) Autonomic Drugs (cont'd)
3.3. Stimulate parasympathetic nervous systemStimulate parasympathetic nervous system Cholinergic agents or parasympathomimeticsCholinergic agents or parasympathomimetics
4.4. Inhibit parasympathetic nervous systemInhibit parasympathetic nervous system Cholinergic-blocking agents, anticholinergics, Cholinergic-blocking agents, anticholinergics,
parasympatholytics, or muscarinic blockersparasympatholytics, or muscarinic blockers
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Cholinergic AgonistsCholinergic Agonists
They act:They act:
Directly → Receptor (choline receptors)Directly → Receptor (choline receptors)
Indirectly → Drugs that inhibit destruction ofIndirectly → Drugs that inhibit destruction of ACh ACh
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Direct-Acting Cholinergic AgonistDirect-Acting Cholinergic Agonist These agents are:These agents are:
Synthetic ester of choline e.g. carbachol & bethanicholSynthetic ester of choline e.g. carbachol & bethanichol Naturally occurring alkaloids e.g. pilocarpine Naturally occurring alkaloids e.g. pilocarpine
They are called “Muscarinic Agonists”They are called “Muscarinic Agonists” ACh has ACh has NONO therapeutic value therapeutic value
The key features of Ach molecule:The key features of Ach molecule: The quaternary ammonium groupThe quaternary ammonium group The ester groupThe ester group
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Muscarinic AgonistsMuscarinic Agonists Substitution of acetyl Substitution of acetyl
gp by carbamyl gp → gp by carbamyl gp → CarbacholCarbachol
Addition of methyl gp Addition of methyl gp on on ββ carbon → carbon → MethacholineMethacholine
Combining these two Combining these two modification → modification → BethanicholBethanichol
Pilocarpine: Pilocarpine: Tertiary Tertiary amineamine
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Effects of Muscarinic AgonistsEffects of Muscarinic Agonists Cardiovascular effectCardiovascular effect:: Heart:Heart: Slowing the heart Slowing the heart BV:BV: Dilation Dilation BP:BP: ↓↓
Exocrine Glands:Exocrine Glands: SweatingSweating LacrymationLacrymation SalivationSalivation
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Effects of Muscarinic Agonists Effects of Muscarinic Agonists
Smooth Muscles:Smooth Muscles: Bronchi:Bronchi: Bronchoconstriction & ↑ secretion Bronchoconstriction & ↑ secretion
GIT:GIT: ↑ motility, sphincter dilation, ↑ gastric secretion ↑ motility, sphincter dilation, ↑ gastric secretion
Urinary Bladder:Urinary Bladder: ↑ motility of detrusor urinae muscle, ↑ motility of detrusor urinae muscle, sphincter dilationsphincter dilation (bladder emptying) (bladder emptying)
Eye:Eye: - Contraction of - Contraction of pupillae sphincter musclespupillae sphincter muscles → miosis and → miosis and widening of filtration angelwidening of filtration angel
- Contraction of - Contraction of ciliary musclesciliary muscles → accommodation → accommodation to near to near vision and vision and opening of opening of canal of schlemmcanal of schlemm
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Clinical Uses of Muscarinic AgonistsClinical Uses of Muscarinic Agonists
Glaucoma:Glaucoma: P Pilocarpine ilocarpine (action lasts for 1 day), the most (action lasts for 1 day), the most effective as being a tertiary amine, it can cross the conjunctival effective as being a tertiary amine, it can cross the conjunctival
membrane.membrane.
Bladder emptying in case of neurological disease or Bladder emptying in case of neurological disease or surgery:surgery: Carbachol & Bethanichol Carbachol & Bethanichol
Hair preparation: Hair preparation: Pilocarpine, Pilocarpine, it promotes hair growth by it promotes hair growth by dilation of scalp blood vessels.dilation of scalp blood vessels.
Atropine Poisoning: Atropine Poisoning: Pilocarpine Pilocarpine
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Adverse Effects of Muscarinic AgonistsAdverse Effects of Muscarinic Agonists
HypotensionHypotension Sweating & SalivationSweating & Salivation BronchospasmBronchospasm Nausea, abdominal pain & diarrheaNausea, abdominal pain & diarrhea Urinary urgencyUrinary urgency MiosisMiosis
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Indirect-actingIndirect-actingcholinergic agonistcholinergic agonist
Inhibition of ChE is Inhibition of ChE is either reversibly or either reversibly or
irreversiblyirreversibly Accumulation of Ach Accumulation of Ach
in the synaptic in the synaptic spaces which can spaces which can
stimulate:stimulate: Both M & N of ANSBoth M & N of ANS
NmNm In brainIn brain
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Reversible AnticholinesteraseReversible Anticholinesterase
Quaternary amines:Quaternary amines: NeostigmineNeostigmine PyridostigminePyridostigmine EdrophoniumEdrophonium
Tertiary amines:Tertiary amines: Physostigmine (eserine)Physostigmine (eserine)
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Effects of Reversible antiChEEffects of Reversible antiChE
An enhancement of cholinergic transmission at An enhancement of cholinergic transmission at cholinergic autonomic synapses & the cholinergic autonomic synapses & the
neuromuscular junctionneuromuscular junction
Physostigmine → Physostigmine → Eye, GIT, Urinary bladder & CNSEye, GIT, Urinary bladder & CNS Neostigmine → Neostigmine → GIT, Urinary bladder & Sk. M.GIT, Urinary bladder & Sk. M.
Pyridostigmine & Edrophonium → Pyridostigmine & Edrophonium → Sk. M.Sk. M.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Clinical Uses of Reversible antiChEClinical Uses of Reversible antiChE
In In glaucomaglaucoma:: Physostigmine (eye drops)Physostigmine (eye drops)
In intestinal & bladder atonyIn intestinal & bladder atony:: Physostigmine & NeostigminePhysostigmine & Neostigmine
In anesthesia:In anesthesia: Neostigmine (IV), it reverses the action of non-Neostigmine (IV), it reverses the action of non-depolarizing neuromuscular blocking drugs. depolarizing neuromuscular blocking drugs.
In overdose of drugs with anticholinergic actions such as In overdose of drugs with anticholinergic actions such as atropine, phenothiazines & TCAatropine, phenothiazines & TCA
In treatment of Myasthenia gravisIn treatment of Myasthenia gravis
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Dental choliergicDental choliergic
1- encourage patients to use good oral 1- encourage patients to use good oral hygiene.hygiene.
2- Raise the patient from the dental chair 2- Raise the patient from the dental chair slowly to avoid hypotension slowly to avoid hypotension
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Cholinergic AntagonistsCholinergic Antagonists
They include 3 classes:They include 3 classes:
1.1. Muscarinic Antagonist Muscarinic Antagonist
2.2. Ganglion Blockers (Nn) Ganglion Blockers (Nn)
3.3. Neuromuscular Blockers (Nm) Neuromuscular Blockers (Nm)
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
1. Muscarinic Antagonists1. Muscarinic Antagonists
They block muscarinic receptors competitively, They block muscarinic receptors competitively, causing inhibition of all muscarinic functionscausing inhibition of all muscarinic functions
They are effective in several clinical situations They are effective in several clinical situations unlike cholinergic agonistsunlike cholinergic agonists
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Muscarinic Antagonists (cont.)Muscarinic Antagonists (cont.)
Drugs belong to this groupDrugs belong to this groupa- Atropine & Hyoscine (scopolamine) a- Atropine & Hyoscine (scopolamine) (natural (natural
alkaloids)alkaloids)
b- Homatropine b- Homatropine (synthetic comp.)(synthetic comp.)
c- Atropine methonitrate c- Atropine methonitrate (quaternary comp.)(quaternary comp.)
d- Ipratropium d- Ipratropium (quaternary comp.)(quaternary comp.)e- Pirenzepine e- Pirenzepine (selective M1 antagonist)(selective M1 antagonist)
f- Cyclopentolate and tropicamidef- Cyclopentolate and tropicamide (tertiary amines (tertiary amines developed for ophthalmic use) developed for ophthalmic use)
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Effects of Muscarinic AntagonistsEffects of Muscarinic Antagonists
Cardiovascular effect:Cardiovascular effect:• Heart:Heart: (block M2 at SA node, tachycardia 80- (block M2 at SA node, tachycardia 80- 90 beat/min) 90 beat/min)
• BV:BV: No effect No effect • BP:BP: No effect No effect
Exocrine glands:Exocrine glands:• At low dose, it inhibits salivary, lachrymal, bronchial & sweat At low dose, it inhibits salivary, lachrymal, bronchial & sweat
glandsglands• Inhibition of secretions by sweat glands can cause elevated Inhibition of secretions by sweat glands can cause elevated
body tempbody temp• It produces uncomfortable dry mouth & skinIt produces uncomfortable dry mouth & skin
• Gastric secretion is only slightly reducedGastric secretion is only slightly reduced
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Effects of Muscarinic Antagonists (cont.)Effects of Muscarinic Antagonists (cont.)
Smooth Muscles:Smooth Muscles:• Eye:Eye:
- Iris: Passive mydriasis & becomes unresponsive to lightIris: Passive mydriasis & becomes unresponsive to light- Ciliary Muscle: Paralysis of accommodation (cycloplegia)Ciliary Muscle: Paralysis of accommodation (cycloplegia)
- In patient with narrow angel glaucoma, IOP may rise dangerously, so In patient with narrow angel glaucoma, IOP may rise dangerously, so short acting antimuscarinic short acting antimuscarinic tropicamidetropicamide or or αα agonist agonist phenylephrinephenylephrine are are
more preferred in ophthalmic examinationmore preferred in ophthalmic examination
CNS:CNS:• Excitatory, at low dose (restlessness) & at high dose (agitation & Excitatory, at low dose (restlessness) & at high dose (agitation &
disorientation)disorientation)• In poisoning, rise in body temp. & hypereactivityIn poisoning, rise in body temp. & hypereactivity
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Clinical Uses of Muscarinic AntagonistsClinical Uses of Muscarinic Antagonists
Cardiovascular:Cardiovascular:• Treatment of heart block Treatment of heart block (atropine)(atropine)
Ophthalmic:Ophthalmic:• Mydriatic Mydriatic
Neurological:Neurological:• Prevention of motion sickness Prevention of motion sickness (scopolamine)(scopolamine)
• Reduce involuntary movement & rigidity in case of Reduce involuntary movement & rigidity in case of Parkinsonism Parkinsonism (benztropine)(benztropine)
• Nocturnal enuresis Nocturnal enuresis
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Clinical Uses of Muscarinic Antagonists (cont.)Clinical Uses of Muscarinic Antagonists (cont.)
Respiratory:Respiratory:• Treatment of asthma & COPD Treatment of asthma & COPD (ipratropium)(ipratropium)
• To dry secretions & prevent reflex bronchconstriction during To dry secretions & prevent reflex bronchconstriction during anesthesia anesthesia (atropine or hyoscine)(atropine or hyoscine)
GIT: GIT: • Antispasmodic action & suppress gastric acid secretionAntispasmodic action & suppress gastric acid secretion• HyoscineHyoscine is used in case of endoscopy & is used in case of endoscopy & pirenzepinepirenzepine in case of in case of
peptic ulcerpeptic ulcer (H2 antagonists are more preferred)(H2 antagonists are more preferred)
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Clinical Uses of Muscarinic Antagonists (cont.)Clinical Uses of Muscarinic Antagonists (cont.)
Antidote for cholinergic agonists:Antidote for cholinergic agonists:• Atropine is used for the treatment of overdoses of Atropine is used for the treatment of overdoses of
cholinesterase inhibitors such as: cholinesterase inhibitors such as: • physostigmine & organophosphate insecticidesphysostigmine & organophosphate insecticides
• Mushrooms (muscarine)Mushrooms (muscarine)• The ability of atropine to enter CNS is of particularly The ability of atropine to enter CNS is of particularly
importanceimportance
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Adverse Effects of Muscarinic AntagonistsAdverse Effects of Muscarinic Antagonists
Dry mouth & blurred visionDry mouth & blurred vision
TachycardiaTachycardia
Restlessness, confusion, hallucination & deliriumRestlessness, confusion, hallucination & delirium
Flushing & feverFlushing & fever
In elderly:In elderly: GlaucomaGlaucoma Prostatic enlargementProstatic enlargement
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
2. Ganglion Blockers (Nn)2. Ganglion Blockers (Nn)
They block nicotinic receptors of autonomic They block nicotinic receptors of autonomic ganglia, therefore they are rarely used ganglia, therefore they are rarely used
therapeutically (experimental tools in therapeutically (experimental tools in pharmacology)pharmacology)
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
3. Neuromuscular Blockers3. Neuromuscular Blockers
Drugs can block neuromuscular transmission in three Drugs can block neuromuscular transmission in three main ways:main ways:
1.1. By inhibiting Ach synthesisBy inhibiting Ach synthesise.g. hemicholinum & triethylcholinee.g. hemicholinum & triethylcholine
2.2. By inhibiting Ach releaseBy inhibiting Ach releasee.g. botulinum toxins, excess Mg, aminoglycosides e.g. botulinum toxins, excess Mg, aminoglycosides antibioticsantibiotics
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
3.3. By interfering with the By interfering with the
postsynaptic action of Ach:postsynaptic action of Ach:
a- a- Depolarizing Blocking Agents (DNMB)Depolarizing Blocking Agents (DNMB)• Produce initial stimulation followed by failure of transmissionProduce initial stimulation followed by failure of transmission• e.g. succinylcholine & decamethoniume.g. succinylcholine & decamethonium
b- b- Competitive Blocking Agents (CNMB)Competitive Blocking Agents (CNMB)• They are pure antagonistsThey are pure antagonists
• e.g. curare & gallaminee.g. curare & gallamine
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Dental antichloinergicDental antichloinergicThese drugs are used to create a dry, oral These drugs are used to create a dry, oral
fieldfield..
SIDE EFFECTSIDE EFFECT..
xerostomia: xerostomia: 1-you have to direct the patient for meticulous 1-you have to direct the patient for meticulous
oral hygine including floss and brushingoral hygine including floss and brushing 2- plenty of water2- plenty of water 3- instruct the patient to avoid alcohol 3- instruct the patient to avoid alcohol
containing preparations, as well as containing preparations, as well as caffeinated beverages as they increase caffeinated beverages as they increase xerostomiaxerostomia
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
4-4- instruct the patient not to use fruit juice and instruct the patient not to use fruit juice and soda as they contain sugar and increase risk soda as they contain sugar and increase risk of cariesof caries
5- recommend to chew sugarless candy to 5- recommend to chew sugarless candy to minimize dry mouth.minimize dry mouth.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic DrugsAdrenergic Drugs These drugs stimulate These drugs stimulate αα and and ββ receptors receptors
throughout the body.throughout the body.
Adrenergic drugs can be classified as having Adrenergic drugs can be classified as having direct action, indirect action, or mixed action.direct action, indirect action, or mixed action.
1.1. Drugs with direct action (epinephrine, Drugs with direct action (epinephrine, norepinephrine, isoproterenol) produce their norepinephrine, isoproterenol) produce their effect by directly stimulating the receptor site.effect by directly stimulating the receptor site.
2.2. Drugs with indirect actionDrugs with indirect action:: a- Stimulate release of endogenous a- Stimulate release of endogenous
norepinephrine which then stimulates the norepinephrine which then stimulates the receptor; amphetamine.receptor; amphetamine.
20
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
b- Inhibition of the membrane reuptake of b- Inhibition of the membrane reuptake of catecholamines by drugs such as cocaine catecholamines by drugs such as cocaine and tricyclic antidepressants.and tricyclic antidepressants.c. Inhibition of monoamine oxidase by drugs c. Inhibition of monoamine oxidase by drugs such as Tranylcypromine.such as Tranylcypromine.
3.3. Drugs with mixed action (ephedrine) either Drugs with mixed action (ephedrine) either directly stimulate the receptor or release directly stimulate the receptor or release endogenous norepinephrine.endogenous norepinephrine.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic DrugsAdrenergic Drugs
PharmacologyPharmacology Central Nervous System (CNS)Central Nervous System (CNS)
• These drugs produce CNS excitation or These drugs produce CNS excitation or alertness.alertness.
• Higher doses produce anxiety, apprehension, Higher doses produce anxiety, apprehension, restlessness, and tremors.restlessness, and tremors.
EyeEye• These drugs can cause mydriasis.These drugs can cause mydriasis.
Respiratory SystemRespiratory System• These drugs cause a relaxation of bronchiole These drugs cause a relaxation of bronchiole
smooth muscles.smooth muscles.
21
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Effects of Adrenergic AgonistsEffects of Adrenergic Agonists Cardiovascular:Cardiovascular:
Heart:Heart: ↑HR, contractility ↑HR, contractility »» ↑↑CO + OCO + O22 consumptionconsumption
↑↑Conductivity (atria, AV node & ventricles)Conductivity (atria, AV node & ventricles)↑↑Excitability Excitability »» arrhythmia arrhythmia
BV:BV: VD or VC depending on the selective activity VD or VC depending on the selective activity of drug and the anatomic site of vesselsof drug and the anatomic site of vessels
e.g. Skin, Splanchnic, Sk.M., renal BVe.g. Skin, Splanchnic, Sk.M., renal BV BPBP:: Depends on effect on heart, PR & venous Depends on effect on heart, PR & venous
returnreturn
The effect of The effect of αα-agonist is different from -agonist is different from ββ-agonist-agonist
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic DrugsAdrenergic Drugs
Metabolic EffectsMetabolic Effects1.1. Hyperglycemia:Hyperglycemia:
Increase liver glycogenolysis Increase liver glycogenolysis ((ββ2)2) Increase glucagon release Increase glucagon release ((ββ2)2) DecreaseDecrease insulininsulin release release ((αα2)2)
1.1. Lipolysis:Lipolysis: Increase hydrolysis of TG into free fatty acids & Increase hydrolysis of TG into free fatty acids &
glycerol glycerol ((ββ3)3) Salivary GlandsSalivary Glands
• These drugs produce vasoconstriction of the These drugs produce vasoconstriction of the salivary glands which leads to decreased salivary salivary glands which leads to decreased salivary flow which results in xerostomia.flow which results in xerostomia.
22
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic Agents (Sympathomimetics) Adrenergic Agents (Sympathomimetics) Primary use:Primary use: depends on receptors activateddepends on receptors activated
Alpha1-receptors:Alpha1-receptors: phenylephrine. nasal phenylephrine. nasal congestion, hypotension, dilation of pupils for congestion, hypotension, dilation of pupils for eye examinationeye examination
Alpha2-receptors:Alpha2-receptors: clonidine. Hypertension clonidine. Hypertension ?? Beta1-receptors:Beta1-receptors: dobutamine and isoprenaline. dobutamine and isoprenaline.
cardiac arrest, heart failure, shockcardiac arrest, heart failure, shock Beta2-receptors: Beta2-receptors: sulbutamol and terbutaline. sulbutamol and terbutaline.
asthma and premature-labor contractions as asthma and premature-labor contractions as they they relax uterine smooth muscle (tocolytics)relax uterine smooth muscle (tocolytics)
Dopaminergic receptors Dopaminergic receptors : dopamine. shock: dopamine. shock
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Anaphylactic reactions:Anaphylactic reactions:
Adrenaline is the first line of treatment for Adrenaline is the first line of treatment for bronchoconstriction & CV collapsebronchoconstriction & CV collapse
Haemostatic: Haemostatic: adrenaline and ephedrineadrenaline and ephedrineMydriatic:Mydriatic: EphedrineEphedrineGlaucoma:Glaucoma: Adrenaline dAdrenaline decrease IOP in ecrease IOP in
open angel glaucoma & decrease aqueous open angel glaucoma & decrease aqueous humor production by VC of ciliary body BVhumor production by VC of ciliary body BV
With local anesthetics:With local anesthetics: Ad & NA Ad & NADepression:Depression: Amphetamine Amphetamine
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
DopamineDopamine
Immediate precursor of NEImmediate precursor of NE Occurs inOccurs in
CNS (act as neurotransmitter)CNS (act as neurotransmitter) Adrenergic nerve ending Adrenergic nerve ending
Adrenal medullaAdrenal medulla
Activates: Activates: αα1(at high doses)1(at high doses)
ββ1 (at small doses)1 (at small doses) D1(occurs in renal vascular bed) D1(occurs in renal vascular bed)
D2 (occurs in presynaptic adrenergic neurons)D2 (occurs in presynaptic adrenergic neurons)
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Pharmacological Effects of Pharmacological Effects of DopamineDopamine
CVS:CVS: +ve chronotropic & inotropic effects+ve chronotropic & inotropic effects At high doses: VC of BVAt high doses: VC of BV
Renal & visceral:Renal & visceral: VD of renal and splanchnic arteriolesVD of renal and splanchnic arterioles Effective in treatment of shock (the drug of choice Effective in treatment of shock (the drug of choice
taken by continuous infusion)taken by continuous infusion)
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Dental UseDental Use VasoconstrictionVasoconstriction
• These drugs are used in dentistry because of their These drugs are used in dentistry because of their vasoconstrictive actions on blood vessels. They are vasoconstrictive actions on blood vessels. They are added to local anesthetics because they prolong added to local anesthetics because they prolong the action of the local anesthetic, reduce the risk the action of the local anesthetic, reduce the risk for systemic toxicity, and help to create a dry field.for systemic toxicity, and help to create a dry field.
• Act as homeostatic agent aids in control Act as homeostatic agent aids in control bleeding bleeding
• Cocaine has limited use as a local anesthesic Cocaine has limited use as a local anesthesic and vasoconstrictor in surgical procedures and vasoconstrictor in surgical procedures involving oral, laryngeal or nasal cavities.involving oral, laryngeal or nasal cavities.
• But close monitoring regard to cardiac effectsBut close monitoring regard to cardiac effects• These drugs raise blood pressure .These drugs raise blood pressure .
24
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Cautions Relevant to DentistryCautions Relevant to Dentistry
1)1) Cocaine and amphetamine-like agents (tricyclic Cocaine and amphetamine-like agents (tricyclic antidepressants as well) could potentiate the antidepressants as well) could potentiate the effects of direct acting agonists such as effects of direct acting agonists such as epinephrine. epinephrine.
2)2) epinephrine can be absorbed systemically after epinephrine can be absorbed systemically after intraoral administration. This epinephrine can intraoral administration. This epinephrine can be taken up by nerve terminals and this uptake be taken up by nerve terminals and this uptake contributes to the termination of the actions of contributes to the termination of the actions of epinephrine. Thus, the risk of hypertension and epinephrine. Thus, the risk of hypertension and other problems associated with systemic other problems associated with systemic absorption of epinephrine will be greater in absorption of epinephrine will be greater in patients taking cocaine or amphetamine-like patients taking cocaine or amphetamine-like drugs. drugs.
2)2)
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic DrugsAdrenergic Drugs
Adverse ReactionsAdverse Reactions The adverse reactions associated with The adverse reactions associated with
these drugs are an extension of the drugs’ these drugs are an extension of the drugs’ pharmacologic effects.pharmacologic effects.
They include:They include:• AnxietyAnxiety• TremorsTremors• TachycardiaTachycardia• Increased blood pressureIncreased blood pressure• ArrhythmiasArrhythmias
23
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Contraindications to use of Contraindications to use of adrenergicsadrenergics
Cardiac dysrhythmias, angina pectorisCardiac dysrhythmias, angina pectoris HypertensionHypertension HyperthyroidismHyperthyroidism Cerebrovascular diseaseCerebrovascular disease Distal areas with a single blood supply such Distal areas with a single blood supply such
as fingers, toes, nose and earsas fingers, toes, nose and ears Renal impairment use cautionRenal impairment use caution
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
epinephrineepinephrine
Affects both alpha and beta receptorsAffects both alpha and beta receptors Usual doses, beta adenergic effects on heart Usual doses, beta adenergic effects on heart
and vascular smooth muscle will and vascular smooth muscle will predominate, high doses, alpha adrenergic predominate, high doses, alpha adrenergic effects will predominateeffects will predominate
Drug of choice for bronchospasm and Drug of choice for bronchospasm and laryngeal edema of anaphylaxislaryngeal edema of anaphylaxis
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
epinephrineepinephrine
Excellent for cardiac stimulant and Excellent for cardiac stimulant and vasoconstrictive effects in cardiac arrestvasoconstrictive effects in cardiac arrest
Added to local anestheticAdded to local anesthetic May be given IV, inhalation, topicallyMay be given IV, inhalation, topically Not PONot PO
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
ClonidineClonidine ALPHAALPHA22 AGONISTS AGONISTS Actions and Therapeutic UsesActions and Therapeutic Uses
1. This drug stimulates alpha1. This drug stimulates alpha22 receptors in the receptors in the
nucleus tractus solitarius (NTS) to decrease nucleus tractus solitarius (NTS) to decrease sympathetic outflow to the heart and blood sympathetic outflow to the heart and blood vessels.vessels.2. The decrease in sympathetic tone results in a 2. The decrease in sympathetic tone results in a decrease in blood pressure.decrease in blood pressure.
3. Clonidine is used in dental practice in the 3. Clonidine is used in dental practice in the management of chronic pain. It can be given management of chronic pain. It can be given orally or in patch form. orally or in patch form.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Inhibits NE release
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Clonidine is a second-line antihypertensive Clonidine is a second-line antihypertensive that has many other uses including opiate that has many other uses including opiate withdrawal, nicotine withdrawal, vascular withdrawal, nicotine withdrawal, vascular headaches, diabetic diarrhea, glaucoma, headaches, diabetic diarrhea, glaucoma, ulcerative colitis.ulcerative colitis.
Side Effects Side Effects
The use of clonidine may result in clinical The use of clonidine may result in clinical symptoms related to dry mouth, such as symptoms related to dry mouth, such as difficulty in swallowing and speech. Chronic difficulty in swallowing and speech. Chronic use of xerostomia-producing drugs is use of xerostomia-producing drugs is associated with a higher incidence of oral associated with a higher incidence of oral candidiasis and dental caries.candidiasis and dental caries.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Monoamine Oxidase InhibitorsMonoamine Oxidase Inhibitors
These drugs inhibit monoamine oxidase and These drugs inhibit monoamine oxidase and are used as antidepressants in psychiatric are used as antidepressants in psychiatric practice. practice.
Can precipitate a hypertensive crisis. Patients Can precipitate a hypertensive crisis. Patients taking MAO inhibitors must not be giventaking MAO inhibitors must not be givendrugs that have indirect sympathomimetic drugs that have indirect sympathomimetic activity or are inactivated by MAO. activity or are inactivated by MAO.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Occasionally, the dentist may find reason to Occasionally, the dentist may find reason to use the vasoconstrictor phenylephrine. use the vasoconstrictor phenylephrine. Because it causes evenBecause it causes evena minor release of norepinephrine from a minor release of norepinephrine from adrenergic nerves and is subject to adrenergic nerves and is subject to metabolism by MAO.metabolism by MAO.
phenylephrine must be avoided in patients phenylephrine must be avoided in patients taking MAO inhibitors. taking MAO inhibitors.
Epinephrine and levonordefrin, which are Epinephrine and levonordefrin, which are most commonly found in local anesthetic most commonly found in local anesthetic solutions, are not contraindicated, since they solutions, are not contraindicated, since they are direct agonists and are largely inactivated are direct agonists and are largely inactivated by catechol-O-methyltransferase. by catechol-O-methyltransferase.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Nonetheless, the avoidance of hemostatic Nonetheless, the avoidance of hemostatic preparations containing high concentrations preparations containing high concentrations of epinephrine isof epinephrine isrecommended.recommended.
Opioids and other CNS depressants should Opioids and other CNS depressants should be used cautiously and usually at lower doses be used cautiously and usually at lower doses ininpatients who are taking MAO inhibitors. patients who are taking MAO inhibitors. Meperidine is absolutely contraindicated.Meperidine is absolutely contraindicated.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Adrenergic Receptor Antagonist Adrenergic Receptor Antagonist αα-Blockers:-Blockers:- Non selective:Non selective: Phenoxybenzamine & Phentolamine Phenoxybenzamine & Phentolamine- αα1-Blocker:1-Blocker: Prazosin, Terazosin, Doxazosin & Prazosin, Terazosin, Doxazosin &
Tamsulosin Tamsulosin - αα2-Blocker:2-Blocker: Yohimbine Yohimbine (Sympatholytic ?)(Sympatholytic ?)
ββ -Blockers:-Blockers:- Non selective:Non selective: Propran Propranolololol , Tim, Timolol olol & Nad& Nadolololol- ββ1-Blocker:1-Blocker: Aten Atenolololol , Metopr, Metoprolol olol & Esm& Esmolololol
αα & & ββ Blocker: Blocker: Labet Labetalolalol & carved & carvediloli lol
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Effects of Effects of αα-adrenoceptor -adrenoceptor AntagonistsAntagonists
The most important effect is CVS effectThe most important effect is CVS effect
They block α1 receptors causing decrease in They block α1 receptors causing decrease in peripheral resistance and consequently BPperipheral resistance and consequently BP
The resultant hypotension provokes reflex The resultant hypotension provokes reflex
tachycardiatachycardia pupillary constrictionpupillary constriction
increased motility of GI tractincreased motility of GI tract
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Alpha 1 antagonists Alpha 1 antagonists
Used in Benign Prostatic Hyperplasia. Used in Benign Prostatic Hyperplasia. Produces smooth muscle relaxation of Produces smooth muscle relaxation of prostate gland and bladder neck. prostate gland and bladder neck.
Pulmonary hypertension in newborns. Can be Pulmonary hypertension in newborns. Can be given SC , IM or IV.given SC , IM or IV.
May be useful in treating pheochromocytomaMay be useful in treating pheochromocytoma May be used in Raynaud’s disease.May be used in Raynaud’s disease. Side Effect : orthostatic hypotensionSide Effect : orthostatic hypotension
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Orthostatic hypotension in Orthostatic hypotension in dentistrydentistry
Orthostatic hypotension is a problem with prazosin Orthostatic hypotension is a problem with prazosin analogs and to a lesser extent tamsulosin. analogs and to a lesser extent tamsulosin. Significantly, orthostatsis is a problem that can be Significantly, orthostatsis is a problem that can be seen with any vasodilator that affects the tone on seen with any vasodilator that affects the tone on venous smooth muscle. venous smooth muscle.
This would include, This would include, organic nitrates, hydralazine, organic nitrates, hydralazine, clonidine, minixodil and the many drugs.clonidine, minixodil and the many drugs.
Orthostatic hypotension or postural hypotension Orthostatic hypotension or postural hypotension occurs when systemic arterial blood pressure falls by occurs when systemic arterial blood pressure falls by more than 20 mmHg upon standing. more than 20 mmHg upon standing.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
In this situation, cerebral perfusion falls and In this situation, cerebral perfusion falls and an individual may become light headed, dizzy an individual may become light headed, dizzy or fatality may occur.or fatality may occur.
In changing from the supine to the standing In changing from the supine to the standing position, gravity tends to cause blood to pool position, gravity tends to cause blood to pool in the lower extremities. However, several in the lower extremities. However, several reflexes, including sympathetically mediated reflexes, including sympathetically mediated venoconstriction minimize this pooling and venoconstriction minimize this pooling and maintain cerebral perfusion. If these reflex maintain cerebral perfusion. If these reflex actions do not occur, then orthostatic actions do not occur, then orthostatic hypotension could result.hypotension could result.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
By blocking the alphaBy blocking the alpha11-receptors associated -receptors associated
with venous smooth muscle, prazosin-like with venous smooth muscle, prazosin-like drugs, inhibit the sympathetically mediated drugs, inhibit the sympathetically mediated vasoconstriction associated with postural vasoconstriction associated with postural changes. Hence, orthostatic hypotension can changes. Hence, orthostatic hypotension can occur. occur.
Drugs like clonidine cause orthostasis due to Drugs like clonidine cause orthostasis due to its CNS actions that block the sympathetic its CNS actions that block the sympathetic reflexes. reflexes.
Vasodilators such as nitrates, minoxidil, Vasodilators such as nitrates, minoxidil, hydralazine or impotence medications cause hydralazine or impotence medications cause orthostasis because of their actions directly orthostasis because of their actions directly on the vasculature.on the vasculature.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
A consideration for patients being treated with A consideration for patients being treated with some sympatholytics is the patient's some sympatholytics is the patient's position position during and after dental proceduresduring and after dental procedures. . Suddenly standing upright after being in a Suddenly standing upright after being in a supine position in the dental chair is very supine position in the dental chair is very probable to cause probable to cause syncopesyncope..
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
beta blocking drugsbeta blocking drugs Decreased heart rateDecreased heart rate Decreased force of contractionDecreased force of contraction Decreased Cardiac OutputDecreased Cardiac Output Slow cardiac conductionSlow cardiac conduction Decreased automaticity of ectopic pacemakersDecreased automaticity of ectopic pacemakers Decreased renin secretion from kidneysDecreased renin secretion from kidneys Decreased BPDecreased BP BronchoconstrictionBronchoconstriction Less effective metabolism of glucose. May result Less effective metabolism of glucose. May result
in more pronounced hypoglycemia and early s/s of in more pronounced hypoglycemia and early s/s of hypoglycemia may be blocked (tachycardia).hypoglycemia may be blocked (tachycardia).
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Uses of Beta blocking Uses of Beta blocking medicationsmedications
Inderal (propranolol) is prototypeInderal (propranolol) is prototype Mainly for cardiovascular disorders (angina, Mainly for cardiovascular disorders (angina,
dysrhythmias, hypertension, Myocardial dysrhythmias, hypertension, Myocardial Infarction and glaucoma.Infarction and glaucoma.
In angina, beta blockers decrease myocardial In angina, beta blockers decrease myocardial oxygen consumption by decreasing rate, BP and oxygen consumption by decreasing rate, BP and contractility. Slow conduction both in SA node contractility. Slow conduction both in SA node and AV node.and AV node.
Useful in pheochromocytoma in conjunction with Useful in pheochromocytoma in conjunction with alpha blockers (counter catecholamine release)alpha blockers (counter catecholamine release)
migrainesmigraines
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Combination selectivityCombination selectivity
Labetalol and carvedilol (Coreg) block alpha Labetalol and carvedilol (Coreg) block alpha 1 receptors to cause vasodilation and beta 1 1 receptors to cause vasodilation and beta 1 and beta 2 receptors which affect heart and and beta 2 receptors which affect heart and lungslungs
Both alpha and beta properties contribute to Both alpha and beta properties contribute to antihypertensive effectsantihypertensive effects
May cause less bradycardia but more May cause less bradycardia but more postural hypotensionpostural hypotension
Less reflex tachycardiaLess reflex tachycardia
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Application to dentistryApplication to dentistry Because nonselective β-blockers block β2Because nonselective β-blockers block β2--
receptor mediated vasodilationreceptor mediated vasodilation, there is a , there is a risk of a risk of a hypertensive episodehypertensive episode following following administration of local anesthetic agents that administration of local anesthetic agents that contain contain epinephrineepinephrine. .
In this situation, the vasoconstrictor actions of In this situation, the vasoconstrictor actions of epinephrineepinephrine at α1 -receptors are not opposed at α1 -receptors are not opposed by the vasodilatory actions of β2-receptors by the vasodilatory actions of β2-receptors resulting in an exaggerated blood pressure resulting in an exaggerated blood pressure response that could be deleterious in patients response that could be deleterious in patients with hypertension or ischemic heart disease. with hypertension or ischemic heart disease.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
2.2. What is implied by «active transport»?What is implied by «active transport»?
a) Transport of drugs through a membrane by a) Transport of drugs through a membrane by means of diffusionmeans of diffusion
b) Transport without energy consumptionb) Transport without energy consumption
c) Engulf of drug by a cell membrane with a c) Engulf of drug by a cell membrane with a new vesicle formationnew vesicle formation
d) Transport against concentration gradientd) Transport against concentration gradient
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
3-Parenteral administration:3-Parenteral administration:
a) Cannot be used with unconsciousness patientsa) Cannot be used with unconsciousness patients
b) Generally results in a less accurate dosage than b) Generally results in a less accurate dosage than oral administrationoral administration
c) Suitable for drugs not absorbed from the gutc) Suitable for drugs not absorbed from the gut
4. Pharmacodynamics involves the study of 4. Pharmacodynamics involves the study of following?following?
a) Mechanisms of drug actiona) Mechanisms of drug action
b) Biotransformation of drugs in the organismb) Biotransformation of drugs in the organism
c) Distribution of drugs in the organismc) Distribution of drugs in the organism
d) Excretion of drug from the organismd) Excretion of drug from the organism
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
5- Target proteins which a drug molecule binds are:5- Target proteins which a drug molecule binds are:
a) Only receptors b) Only ion channelsa) Only receptors b) Only ion channels
c) Only transporters d) All of the abovec) Only transporters d) All of the above
6-An agonist is a substance that:6-An agonist is a substance that:
a) Interacts with the receptor without producing any a) Interacts with the receptor without producing any effecteffect
b) Interacts with the receptor and initiates changes in b) Interacts with the receptor and initiates changes in cell function, producing various effectscell function, producing various effects
c) Interacts with plasma proteins and doesn’t produce c) Interacts with plasma proteins and doesn’t produce any effectany effect